These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 28679406

  • 1. The common promoter polymorphism rs11666254 downregulates FPR2/ALX expression and increases risk of sepsis in patients with severe trauma.
    Zhang H, Lu Y, Sun G, Teng F, Luo N, Jiang J, Wen A.
    Crit Care; 2017 Jul 06; 21(1):171. PubMed ID: 28679406
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.
    Waechter V, Schmid M, Herova M, Weber A, Günther V, Marti-Jaun J, Wüst S, Rösinger M, Gemperle C, Hersberger M.
    J Immunol; 2012 Feb 15; 188(4):1856-67. PubMed ID: 22246625
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis.
    Gobbetti T, Coldewey SM, Chen J, McArthur S, le Faouder P, Cenac N, Flower RJ, Thiemermann C, Perretti M.
    Proc Natl Acad Sci U S A; 2014 Dec 30; 111(52):18685-90. PubMed ID: 25512512
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic regulation of the formyl peptide receptor 2 gene.
    Simiele F, Recchiuti A, Patruno S, Plebani R, Pierdomenico AM, Codagnone M, Romano M.
    Biochim Biophys Acta; 2016 Oct 30; 1859(10):1252-8. PubMed ID: 27424221
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense.
    Pierdomenico AM, Patruno S, Codagnone M, Simiele F, Mari VC, Plebani R, Recchiuti A, Romano M.
    Sci Rep; 2017 Oct 18; 7(1):13519. PubMed ID: 29044225
    [Abstract] [Full Text] [Related]

  • 11. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J, Ferreirós N, Pirotte B, Geisslinger G, Offermanns S.
    Biochem Pharmacol; 2013 Jun 15; 85(12):1795-802. PubMed ID: 23643932
    [Abstract] [Full Text] [Related]

  • 12. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
    Maderna P, Cottell DC, Toivonen T, Dufton N, Dalli J, Perretti M, Godson C.
    FASEB J; 2010 Nov 15; 24(11):4240-9. PubMed ID: 20570963
    [Abstract] [Full Text] [Related]

  • 13. N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.
    Rabiet MJ, Macari L, Dahlgren C, Boulay F.
    J Biol Chem; 2011 Jul 29; 286(30):26718-31. PubMed ID: 21543323
    [Abstract] [Full Text] [Related]

  • 14. Lipoxin A4 Attenuates the Inflammatory Response in Stem Cells of the Apical Papilla via ALX/FPR2.
    Gaudin A, Tolar M, Peters OA.
    Sci Rep; 2018 Jun 11; 8(1):8921. PubMed ID: 29892010
    [Abstract] [Full Text] [Related]

  • 15. Functional significance of the Toll-like receptor 4 promoter gene polymorphisms in the Chinese Han population.
    Chen K, Wang YT, Gu W, Zeng L, Jiang DP, Du DY, Hu P, Duan ZX, Liu Q, Huang SN, Jiang JX.
    Crit Care Med; 2010 May 11; 38(5):1292-9. PubMed ID: 20228685
    [Abstract] [Full Text] [Related]

  • 16. A functional variant of lipopolysaccharide binding protein predisposes to sepsis and organ dysfunction in patients with major trauma.
    Zeng L, Gu W, Zhang AQ, Zhang M, Zhang LY, Du DY, Huang SN, Jiang JX.
    Ann Surg; 2012 Jan 11; 255(1):147-57. PubMed ID: 22167001
    [Abstract] [Full Text] [Related]

  • 17. Hemin impairs resolution of inflammation via microRNA-144-3p-dependent downregulation of ALX/FPR2.
    Sun G, Lu Y, Zhao L, Xia W, Zhang H, Wang L, Zhang L, Wen A.
    Transfusion; 2019 Jan 11; 59(1):196-206. PubMed ID: 30499593
    [Abstract] [Full Text] [Related]

  • 18. Identification of haplotype tag SNPs within the whole myeloid differentiation 2 gene and their clinical relevance in patients with major trauma.
    Zeng L, Zhang AQ, Gu W, Zhou J, Zhang LY, Du DY, Zhang M, Wang HY, Jiang JX.
    Shock; 2012 Apr 11; 37(4):366-72. PubMed ID: 22266968
    [Abstract] [Full Text] [Related]

  • 19. FPR2/ALX activation reverses LPS-induced vascular hyporeactivity in aorta and increases survival in a pneumosepsis model.
    Horewicz VV, Crestani S, de Sordi R, Rezende E, Assreuy J.
    Eur J Pharmacol; 2015 Jan 05; 746():267-73. PubMed ID: 25478948
    [Abstract] [Full Text] [Related]

  • 20. Effects of the ALX/FPR2 receptors of lipoxin A4 on lung injury induced by fat embolism syndrome in rats.
    Gan N, Zhang R, Xu X, Wang Y, Qi A, Zhang Y, Wang A.
    Biomed Pharmacother; 2019 Apr 05; 112():108595. PubMed ID: 30784911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.